ES3029733T3 - Composition for controlled ovarian stimulation - Google Patents

Composition for controlled ovarian stimulation Download PDF

Info

Publication number
ES3029733T3
ES3029733T3 ES19722535T ES19722535T ES3029733T3 ES 3029733 T3 ES3029733 T3 ES 3029733T3 ES 19722535 T ES19722535 T ES 19722535T ES 19722535 T ES19722535 T ES 19722535T ES 3029733 T3 ES3029733 T3 ES 3029733T3
Authority
ES
Spain
Prior art keywords
recombinant
dose
hcg
fsh
per day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES19722535T
Other languages
English (en)
Spanish (es)
Inventor
Ian Cottingham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring BV filed Critical Ferring BV
Application granted granted Critical
Publication of ES3029733T3 publication Critical patent/ES3029733T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
ES19722535T 2018-04-30 2019-04-25 Composition for controlled ovarian stimulation Active ES3029733T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP18170138 2018-04-30
EP18172725 2018-05-16
EP19152465 2019-01-18
PCT/EP2019/060577 WO2019211153A1 (en) 2018-04-30 2019-04-25 Composition for controlled ovarian stimulation

Publications (1)

Publication Number Publication Date
ES3029733T3 true ES3029733T3 (en) 2025-06-25

Family

ID=66440004

Family Applications (1)

Application Number Title Priority Date Filing Date
ES19722535T Active ES3029733T3 (en) 2018-04-30 2019-04-25 Composition for controlled ovarian stimulation

Country Status (15)

Country Link
US (2) US20210038694A1 (pl)
EP (2) EP3787667B1 (pl)
JP (2) JP2021522268A (pl)
CN (1) CN112088011A (pl)
DK (1) DK3787667T3 (pl)
ES (1) ES3029733T3 (pl)
FI (1) FI3787667T3 (pl)
HR (1) HRP20250452T1 (pl)
HU (1) HUE071268T2 (pl)
LT (1) LT3787667T (pl)
PL (1) PL3787667T3 (pl)
RS (1) RS66871B1 (pl)
SI (1) SI3787667T1 (pl)
TW (1) TW201945024A (pl)
WO (1) WO2019211153A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020002235A (es) 2017-09-01 2020-07-20 Ferring Bv Composicion para la estimulacion ovarica controlada.
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
TW202210096A (zh) * 2020-05-29 2022-03-16 荷蘭商菲林公司 治療不育症之方法
TW202237173A (zh) * 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
KR20240167660A (ko) * 2022-04-01 2024-11-27 훼링 비.브이. 불임의 치료를 위한 혼합 프로토콜
AU2023275943A1 (en) * 2022-05-26 2024-10-17 Ferring B.V. Compositions and methods for treatment of infertility in males
WO2025149590A1 (en) * 2024-01-09 2025-07-17 Ferring B.V. Compositions and methods for controlled ovarian stimulation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2850980B1 (fr) 2003-02-06 2005-04-15 Afssa Sequences specifiques d'e. coli 0145, et leurs utilisations
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
TWI532495B (zh) 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
PT2621517E (pt) * 2010-09-29 2015-10-16 Ferring Bv Composição para uso no tratamento da infertilidade
WO2012127501A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for improving endometrial thickness during ovarian stimulation
BR112014001274A2 (pt) * 2011-07-18 2017-04-18 Arts Biologics As composto de hormônio luteinizante, e, composição farmacêutica
JO3092B1 (ar) * 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
EP3283097B1 (en) * 2015-04-17 2020-02-12 Ferring B.V. Fsh for treatment of infertility
SI3286209T1 (sl) 2015-04-24 2021-01-29 Ferring Bv Postopek izdelave gonadotropina

Also Published As

Publication number Publication date
RS66871B1 (sr) 2025-06-30
TW201945024A (zh) 2019-12-01
HUE071268T2 (hu) 2025-08-28
EP4534145A2 (en) 2025-04-09
JP2024056722A (ja) 2024-04-23
PL3787667T3 (pl) 2025-07-28
EP3787667B1 (en) 2025-03-26
CN112088011A (zh) 2020-12-15
SI3787667T1 (sl) 2025-06-30
EP4534145A3 (en) 2025-07-02
DK3787667T3 (da) 2025-06-16
JP2021522268A (ja) 2021-08-30
EP3787667A1 (en) 2021-03-10
WO2019211153A1 (en) 2019-11-07
FI3787667T3 (fi) 2025-07-04
US20210038694A1 (en) 2021-02-11
LT3787667T (lt) 2025-05-12
HRP20250452T1 (hr) 2025-06-06
US20250114434A1 (en) 2025-04-10

Similar Documents

Publication Publication Date Title
ES3029733T3 (en) Composition for controlled ovarian stimulation
US20250325637A1 (en) Compositions and methods for controlled ovarian stimulation
US20240024424A1 (en) Composition for controlled ovarian stimulation
CA3197742A1 (en) Compositions and methods for controlled ovarian stimulation
WO2025149590A1 (en) Compositions and methods for controlled ovarian stimulation
HK40041223A (en) Composition for controlled ovarian stimulation
HK40041223B (en) Composition for controlled ovarian stimulation
HK40055068B (en) Compositions comprising a recombinant fsh for the treatment of infertility
HK40055068A (en) Compositions comprising a recombinant fsh for the treatment of infertility
EA046396B1 (ru) Композиции и способы для контролируемой стимуляции яичников